Showing results (731-740 of 1,321) with videos related to
Sort By:
Pageof 133
Biochimica Et Biophysica Acta|October 19, 2002
A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiencyJürgen G Okun, Stefan Kölker, Andreas Schulze, et al.Annals of Neurology|October 24, 1997
New familial mitochondrial encephalopathy with macrocephaly, cardiomyopathy, and complex I deficiencyC Dionisi-Vici, W Ruitenbeek, G Fariello, et al.Journal of Lipid Research|January 1, 1992
Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentographyH J ten Brink, F Stellaard, C M van den Heuvel, et al.The Journal of Applied Psychology|January 28, 2021
No guts, no glory? How risk-taking shapes dominance, prestige, and leadership endorsementGerben A van Kleef, Marc W Heerdink, Arik Cheshin, et al.Clinical Biochemistry|February 19, 2002
Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MSM F Silva, J Selhorst, H Overmars, et al.Human Molecular Genetics|March 18, 2005
Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiencyIris Oezen, Walter Rossmanith, Sonja Forss-Petter, et al.Human Mutation|April 21, 2005
Identification of novel mutations in classical galactosemiaAnnet M Bosch, Lodewijk Ijlst, Wendy Oostheim, et al.The Biochemical Journal|November 13, 2004
Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouseNaomi van Vlies, Liqun Tian, Henk Overmars, et al.Journal of the National Cancer Institute|May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancerM J Piccart, M Gore, W Ten Bokkel Huinink, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2010
AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trialPer-Uno Malmström, Angelica S I Loskog, Camilla A Lindqvist, et al.Pageof 133